Asustek is shipping its upcoming Vivo Tab RT tablet starting at US$599, which will cost more than Windows RT tablets from Microsoft and Dell, which have an entry price of $499. Asus is shipping the tablet with a dock accessory. Buyers ...
Tags: Asustek, Vivo Tab RT tablet, Windows RT tablets, Microsoft, Dell
Where are the sub-$300 Windows RT tablets? That's a question that might not be answered until Friday, when tablet makers finally put them on sale. During the Windows 8 launch presentation here, Microsoft's corporate vice president of ...
IDG News Service - New Windows RT tablets announced at the IFA trade show in Berlin have intensified competition among ARM-based chip makers, which are adding unique capabilities to processors so tablets become more attractive to buyers ...
Tags: Windows RT tablet, Qualcomm, chip, tablet
Lonza has received a contract from Intellect Neurosciences to develop and manufacture the antibody drug conjugate, Conjumab-A. Under the contract, Lonza will supply the preclinical study material for the drug optimization and drug ...
Tags: Lonza, antibody drug, Neurosciences, antibody drug conjugate
During the integration of three separate groups of Swiss telecoms provider SwissCom, the business intelligence (BI) function was the only place to get a view of the whole organisation. Following its decision in 2008 to converge groups ...
Tags: SwissCom, business intelligence, enterprise resource planning
IDG News Service - This year at the IFA consumer electronics show in Berlin vendors introduced and demonstrated a plethora of ultra-high resolution TVs, hybrid tablets based on Microsoft's upcoming operating systems, as well as the first ...
Tags: IFA, Hybrid Tablets, 4K TVs, Berlin
Animal fertilityassessment is crucial for animal husbandry in the UK:farmers need to know that their breeding animals are healthy before the breeding season so that lambing and calving can be organised effectively.Linkam warms stages are ...
Tags: animal fertility assessment, animal husbandry, Linkam warms stages
GlycoVaxyn and GlaxoSmithKline Biologicals(GSK)have signed a research partnership for the development of new bacterial vaccines. The collaboration,planned for three years,will leverage GlycoVaxyn's bio-conjugation technology in developing ...
Tags: GSK, Glycovaxyn, bacterial vaccines, Partnership
ARM has joined forces with Microsoft to tune the Windows OS to work on processors based on ARM’s 64-bit architecture, the company said this week. Ian Forsyth, programme manager at ARM, could not comment on a specific release date ...
Tags: 64 bit processor, ARM, Microsoft, Qualcomm, Windows
Immunomedics has developed two new classes of bispecific antibodies, DOCK-AND-LOCK (DNL) complexes using its patented platform technology that enables site-specific conjugation of two self-assembling modules. The bispecific antibodies ...
Proteonomix, a developer of human cells based therapeutics, has licensed rights to use its anti-tumor technology. The technology comprises methods for isolation and propagation of the primary human cells, gene profiles obtained from the ...
Tags: Proteonomix, anti-tumor technology
The US Food and Drug Administration (FDA) has granted 510(k) clearance to AngioDynamics' BioFlo peripherally inserted central catheters (PICCs) with a permanent and non-eluting integral polymer Endexo technology. The BioFlo PICCs is ...
Tags: FDA, clearance, PICCs, BioFlo PICCs, PASV Valve technology
Vascular Nanotransfer Technologies has reported in vivo test results of its paclitaxel nanocarrier-based Drug Coated Balloon (DCB) technology, designed for patients with coronary in-stent restenosis and peripheral vascular disease. ...
Tags: Drug Coated Balloon, medical technology, clinical trial
Cardionovum has started in vivo testing of its paclitaxel-coated Restore drug-eluting balloon (DEB) to evaluate drug-in-tissue concentration. The Restore DEB, including EXPRESS drug-release platform, is designed for the treatment of ...
Tags: drug-eluting balloon, clinical product, clinical trial
Arterial Remodeling Technologies has reported positive results of its biodegradable stent from first-in-human Arterial Remodeling Transient DIsmantling Vascular Angioplasty (ARTDIVA) study. The bioresorbable stent, which promotes ...
Tags: clinical trial, clinical technology, clinical research